Healthcare - Biotechnology - NASDAQ - IL
$ 2.23
1.36 %
$ 156 M
Market Cap
-5.57
P/E
BALANCE SHEET
107 M
ASSETS
22.9 M
LIABILITIES
84.5 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Alpha Tau Medical Ltd.
| Current Assets | 85.8 M |
| Cash & Short-Term Investments | 81.8 M |
| Receivables | 0 |
| Other Current Assets | 3.97 M |
| Non-Current Assets | 21.6 M |
| Long-Term Investments | 0 |
| PP&E | 21.2 M |
| Other Non-Current Assets | 471 K |
| Current Liabilities | 7.1 M |
| Accounts Payable | 2.57 M |
| Short-Term Debt | 1.06 M |
| Other Current Liabilities | 3.47 M |
| Non-Current Liabilities | 15.8 M |
| Long-Term Debt | 12.2 M |
| Other Non-Current Liabilities | 3.6 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 15.8 | 5.8 | 23.2 | 15.6 | 1.8 |
| Short Term Investments | 69.1 | 98.7 | 8.1 | 30.4 | 26.3 |
| Receivables | 0 | 0 | 0 | 0 | 0.6 |
| Inventory | 0 | (1.1) | (8.2) | (29.8) | 1.1 |
| Other Current Assets | 4.0 | 1.9 | 1.3 | 1.4 | 1.7 |
| Total Current Assets | 85.8 | 106.5 | 32.6 | 47.5 | 29.8 |
| PP&E | 21.2 | 13.3 | 7.5 | 5.4 | 1.7 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.5 | 0.4 | 2.0 | 0.1 | 16 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 107.4 | 120.1 | 42.2 | 53.0 | 31.6 |
| LIABILITIES | |||||
| Accounts Payable | 2.6 | 1.4 | 1.2 | 1.0 | 0.9 |
| Short Term Debt | 1.1 | 1.3 | 0 | 0 | 0 |
| Other Current Liabilities | 3.5 | 1.6 | 3.2 | 1.1 | 0.5 |
| Total Current Liabilities | 7.1 | 4.3 | 4.4 | 2.1 | 1.3 |
| Long Term Debt | 12.2 | 4.5 | 0 | 54.0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 3.6 | 5.6 | 72.6 | 5.4 | 30.4 |
| Total Liabilities | 22.9 | 14.5 | 77.0 | 61.4 | 31.8 |
| EQUITY | |||||
| Common Stock | 0 | 0 | 0 | 690 | 0 |
| Retained Earnings | (115.8) | (86.6) | (52.8) | (25.6) | (16.7) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 60 K | 0 |
| Total Equity | 84.5 | 105.7 | (34.8) | (8.4) | (0.2) |
| Total Liabilities and Equity | 107.4 | 120.1 | 42.2 | 53.0 | 31.6 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 69.4 | 63.5 | 40.5 | 40.4 | 67.6 |